Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility

Fankhauser, Christian D; Afferi, Luca; Stroup, Sean P; Rocco, Nicholas R; Olson, Kathleen; Bagrodia, Aditya; Baky, Fady; Cazzaniga, Walter; Mayer, Erik; Nicol, David; Islamoglu, Ekrem; de Vergie, Stephane; Saoud, Ragheed; Eggener, Scott E; Nazzani, Sebastiano; Nicolai, Nicola; Hugar, Lee; Sexton, Wade J; Matei, Deliu-Victor; De Cobelli, Ottavio

doi:10.1007/s00345-022-03974-9

Citations

Citation copied

Fankhauser, C. D., Afferi, L., Stroup, S. P., Rocco, N. R., Olson, K., Bagrodia, A., Baky, F., Cazzaniga, W., Mayer, E., Nicol, D., Islamoglu, E., de Vergie, S., Saoud, R., Eggener, S. E., Nazzani, S., Nicolai, N., Hugar, L., Sexton, W. J., Matei, D.-V., … Mattei, A. (2022). Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility. World Journal of Urology, 40(6), 1505–1512. https://doi.org/10.1007/s00345-022-03974-9

Abstract

PURPOSE

To describe the perioperative safety, functional and immediate post-operative oncological outcomes of minimally invasive RPLND (miRPLND) for testis cancer.

METHODS

We performed a retrospective multi-centre cohort study on testis cancer patients treated with miRPLND from 16 institutions in eight countries. We measured clinician-reported outcomes stratified by indication. We performed logistic regression to identify predictors for maintained postoperative ejaculatory function.

RESULTS

Data for 457 men undergoing miRPLND wer